BioWorld MedTech

Dec. 4, 2015

MedTech Forum 2015: Brussels disappoints again pushing regulatory reform back 6 months

BRUSSELS – There are some people who are still optimists, believing that the European Union (EU) will make a definitive decision on something sometime soon. Read More

Inside the Beltway: Federal Circuit passes on en banc hearing for Sequenom

Company Eyes Approval in 2017: Stimrelieve receives IDE to launch craniofacial pain treatment device trial

MDT-COV freed up $9.3 billion: Company to reveal cash deployment plans in the 'very near' future

Financings: Nxthera raises $40M in funding round led by Boston Scientific

World in Review: Biontech, Shuwen deliver Mammatyper test in China

Agreements/contracts: Find, Cepheid expand collaboration to help low-income patients

Hit Bits: Two new Veeva cloud products now available

Daily M&A:Novartis could sell contact lens products to help boost Alcon

Briefly Noted

Product briefs

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...